indocyanine green has been researched along with Adverse Drug Event in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Cho, HJ; Kang, DH; Kim, JW; Kim, K; Lim, SH | 1 |
Bouma, GJ; de Witt Hamer, PC; Germans, MR; van Boven, LJ; Zwinderman, KA | 1 |
Chen, TL; Chuang, LH; Lai, CC; Lin, KK; Wu, WC; Yeung, L | 1 |
Haritoglou, C; Kampik, A | 1 |
Abe, T; Fuse, N; Kunikata, H; Murata, H; Nakagawa, Y; Nishida, K; Sagara, Y; Sato, H; Tamai, M; Tomita, H; Wada, Y | 1 |
6 other study(ies) available for indocyanine green and Adverse Drug Event
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Atrophy; Choroidal Neovascularization; Coloring Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2020 |
Blood volume measurement with indocyanine green pulse spectrophotometry: dose and site of dye administration.
Topics: Adult; Aged; Blood Volume; Blood Volume Determination; Catheterization; Coloring Agents; Densitometry; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Hemodynamics; Humans; Indocyanine Green; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Spectrophotometry; Subarachnoid Hemorrhage | 2010 |
Prevention of indocyanine green toxicity on retinal pigment epithelium with whole blood in stain-assisted macular hole surgery.
Topics: Adult; Aged; Aged, 80 and over; Basement Membrane; Blood; Cell Survival; Cells, Cultured; Coloring Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Pigment Epithelium of Eye; Prospective Studies; Retinal Perforations; Staining and Labeling; Tomography, Optical Coherence; Visual Acuity | 2005 |
[Staining techniques in macular surgery].
Topics: Drug-Related Side Effects and Adverse Reactions; Epiretinal Membrane; Humans; Indocyanine Green; Retinal Perforations; Sensitivity and Specificity; Triamcinolone; Trypan Blue; Vitreoretinopathy, Proliferative | 2006 |
Hypothermia protects cultured human retinal pigment epithelial cells against indocyanine green toxicity.
Topics: Cell Survival; Cells, Cultured; Coloring Agents; Cytoprotection; Drug-Related Side Effects and Adverse Reactions; Humans; Hypothermia, Induced; Indocyanine Green; Pigment Epithelium of Eye | 2007 |